Mortality from COVID-19 in Patients with COPD: A US Study in the N3C Data Enclave

Figures & data

Table 1 Characteristics of Patients with COVID-19 (PCR Positive) in the N3C Data Enclave

	COPD (n = 7449)	NO COPD (n = 273,963)	p-value
Age, mean (years)	70.5	57.9
Gender
Female, No. (%)	3500 (47%)	147,639 (54%)	< 0.001
Race			< 0.001
Black, No. (%)	1412 (19%)	47,046 (17%)
White, No. (%)	5310 (71%)	174,487 (64%)
Asian, No. (%)	93 (1%)	6765 (2%)
Hispanic, No. (%)	294 (4%)	32,331 (12%)	< 0.001
Comorbidities
Diabetes, No. (%)	2849 (38%)	59,459 (22%)	< 0.001
Obesity, No. (%)	2539 (34%)	64,591 (24%)	< 0.001
CKD, No. (%)	2328 (31%)	28,195 (10%)	< 0.001
HTN, No. (%)	5541 (74%)	108,105 (39%)	< 0.001
Hospitalizations, n (%)	4631 (62%)	76,875 (28%)	< 0.001
Deaths, n (%)	1107 (15%)	10,126 (4%)	< 0.001

Figure 1 Multivariable logistic regression analysis of risk factors for death from COVID-19 in the N3C data set. Multivariable logistic regression analysis demonstrated that age, male gender and presence of COPD, obesity, chronic kidney disease, and diabetes were all associated with increased odds of death from COVID-19 in the N3C data set.